Besides type 2 inflammation in asthma, what other conditions can cause elevated serum eosinophil counts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Elevated Serum Eosinophils Beyond Type 2 Asthma

Elevated serum eosinophils can result from numerous conditions including parasitic infections, drug hypersensitivity reactions, eosinophilic gastrointestinal disorders (particularly eosinophilic esophagitis), vasculitides (especially eosinophilic granulomatosis with polyangiitis/EGPA), hypereosinophilic syndromes (both lymphocytic and myeloproliferative variants), allergic bronchopulmonary aspergillosis, and less commonly HIV infection, IgG4-related disease, and certain malignancies.

Primary Eosinophilic Disorders

Hematological Conditions

  • Hypereosinophilic syndromes represent a critical differential, divided into:
    • Lymphocytic variants
    • Myeloproliferative variants (characterized by FIP1L1 fusion genes) 1
  • These conditions require specific workup including genetic testing and bone marrow evaluation when eosinophil counts are persistently elevated without clear secondary cause

Vasculitis

  • Eosinophilic granulomatosis with polyangiitis (EGPA) is the most important vasculitic cause 1
    • Presents with asthma, eosinophilia, rhinosinusitis, and lung infiltrates
    • 30-40% are ANCA-positive (mostly MPO-ANCA)
    • ANCA-positive patients show more vasculitis features: glomerulonephritis, neuropathy, purpura
    • ANCA-negative patients have more cardiomyopathy and lung involvement
    • Critical pitfall: ANCA are usually NOT present in primary eosinophilic disorders, so ANCA testing helps distinguish EGPA from other causes 1

Gastrointestinal Causes

Eosinophilic Esophagitis (EoE)

  • Defined by ≥15 eosinophils per 0.3 mm² on esophageal biopsy with compatible symptoms 2
  • Strongly associated with atopic conditions and frequently coexists with asthma 3
  • Prevalence has increased dramatically to 63/100,000 since 2017 2
  • Shows seasonal variation linked to pollen exposure 2
  • Important: Peripheral eosinophilia may be present but diagnosis requires tissue confirmation

Infectious Causes

Parasitic Infections

  • Remain a major cause globally of eosinophilia 1
  • Must be excluded in appropriate epidemiological contexts before attributing eosinophilia to other causes

Allergic and Hypersensitivity Disorders

Allergic Bronchopulmonary Aspergillosis (ABPA)

  • Hypersensitivity reaction to Aspergillus species 1, 4
  • Presents with asthma-like symptoms, elevated IgE, and eosinophilia
  • Requires specific diagnostic criteria including imaging and serological testing

Drug Hypersensitivity

  • Drug reaction with eosinophilia and systemic symptoms (DRESS) 4
  • Eosinophilic pneumonia can be drug-induced 5
  • Temporal relationship to medication exposure is key diagnostic feature

Pulmonary Eosinophilic Disorders

Eosinophilic Pneumonia

  • Idiopathic chronic eosinophilic pneumonia is associated with asthma in most cases 5
  • Distinguished from asthma by radiographic infiltrates and higher tissue eosinophilia
  • Responds dramatically to systemic corticosteroids

COPD with Eosinophilia

  • 10-40% of COPD patients demonstrate eosinophilic inflammation 6
  • Sputum eosinophilia predicts corticosteroid responsiveness in both asthma and COPD 6
  • Viral infections and inflammatory responses drive eosinophil elevation in eosinophilic COPD 7

Other Conditions

Less Common Causes

  • HIV infection 1
  • IgG4-related disease 1
  • Hypersensitivity pneumonitis 4
  • Occupational exposures 4
  • Neoplastic disorders 4

Diagnostic Approach

Key Distinguishing Features

When evaluating unexplained eosinophilia:

  1. Obtain ANCA testing - positivity (especially MPO-ANCA) suggests EGPA over primary eosinophilic disorders 1

  2. Assess for systemic involvement:

    • Cardiac symptoms → consider EGPA (especially if ANCA-negative)
    • Renal involvement, neuropathy, purpura → consider EGPA (especially if ANCA-positive)
    • Dysphagia/food impaction → obtain esophageal biopsies for EoE 2
  3. Evaluate medication history for drug-induced eosinophilia 4

  4. Consider parasitic infection based on travel/exposure history 1

  5. Look for FIP1L1 fusion genes if myeloproliferative hypereosinophilic syndrome suspected 1

Critical Caveat

Corticosteroid exposure significantly affects blood eosinophil counts 8, so interpretation must account for recent or ongoing steroid therapy. Longitudinal measurements provide more reliable assessment than single values.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.